Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

1(20%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

60%

Ph phase_1

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Terminated(1)

Detailed Status

Completed3

Recruiting1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (25.0%)

N/A3 (75.0%)

Trials by Status

completed360%

recruiting120%

withdrawn120%

Recent Activity

1 active trials

Showing 5 of 5

recruitingnot_applicable

The Effect of Laparoscopic Splenectomy on Liver Reserve Function for Cirrhosis Patients

NCT05325424

completednot_applicable

The Effect of Laparoscopic Splenectomy on the Immune Function for Cirrhosis Patients

NCT05339269

completedphase_1

Clinical Trials (5)

Showing 5 of 5 trials

NCT05325424Not Applicable

The Effect of Laparoscopic Splenectomy on Liver Reserve Function for Cirrhosis Patients

Recruiting

NCT05339269Not Applicable

The Effect of Laparoscopic Splenectomy on the Immune Function for Cirrhosis Patients

Completed

NCT04763733Phase 1

Laparoscopic Splenectomy in Children

Completed

NCT04502147

How to Provide Vascular Control of Splenic Artery Aneurysm? Report of Two Cases

Completed

NCT01276561Not Applicable

Single Incision Versus Standard Laparoscopic Splenectomy

Withdrawn

All 5 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 5